Get in touch
Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.
Next-generation sequencing of exon 9 of the CALR (calreticulin) gene for enhanced detection of low levels of insertion/deletion mutations. This test may be ordered separately (if JAK2 analysis, specifically JAK2 V617F, is already performed), as a reflex from JAK2 V617F Mutation Analysis, or as part of the MPN JAK2 V617F with Sequential Reflex to JAK2 Exon 12-15, CALR, and MPL. Note: This assay replaces the former Calreticulin (CALR) Mutation Analysis performed by fragment analysis/bi-directional sequencing. NY samples are still processed by fragment analysis/bi-directional sequencing until further notice.
Bone Marrow Aspirate: 1-2 mL in EDTA tube. Sodium Heparin is acceptable.
Peripheral Blood: 3-5 mL in EDTA tube. Sodium Heparin is acceptable.
Note: Test is DNA-based. Please select Extract & Hold - DNA if specimen hold service is desired.
*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.
Last Updated: October 13, 2025